Literature DB >> 27347317

Tumor-suppressive microRNA-195-5p regulates cell growth and inhibits cell cycle by targeting cyclin dependent kinase 8 in colon cancer.

Qifeng Luo1, Zhenyu Zhang1, Zhenling Dai1, Shiva Basnet1, Shuping Li2, Bin Xu3, Haiyan Ge1.   

Abstract

MicroRNAs (miRNAs) are key regulators in gene expression. Dysregulation of them in cancer development have been attracting increasing attention. The purpose of this study was to investigate the potential role of miR-195-5p in colon cancer (CC) biology. Expression of miR-195-5p in CC specimens and adjacent normal tissues were measured by quantitative polymerase chain reaction (qPCR). Overexpression of miR-195-5p was established by transfecting mimics into SW480 CC cells. Following, MTT assays, wound healing assays, invasion assays and cell cycle assays were used to explore the potential function of miR-195-5p in SW480 cells. Dual-luciferase reporter assays were performed to validate the regulation of a putative target of miR-195-5p, in corroboration with qPCR and western blot assays. The expression of miR-195-5p in CC specimens was significantly lower than that of adjacent normal tissues (P < 0.05). Overexpression of miR-195-5p inhibited cellular growth, suppressed cellular migration and invasion, and led to cell cycle arrest at G1 phase in vitro. Dual-luciferase reporter assays showed that miR-195-5p binds the 3'-untranslated region (UTR) of CDK8, suggesting that CDK8 should be a direct target of miR-195-5p. Moreover, qPCR and western blot assays confirmed CDK8 mRNA and protein levels were reduced after overexpression of miR-195-5p. These findings are supportive of miR-195-5p as a novel tumor suppressor in CC, thus may serve as a new strategy for cancer treatment.

Entities:  

Keywords:  CDK8; MiR-195-5p; SW480; cell cycle; colon cancer

Year:  2016        PMID: 27347317      PMCID: PMC4891422     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  19 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.

Authors:  Yang Ni; Long Meng; Liguang Wang; Wei Dong; Hongchang Shen; Guanghui Wang; Qi Liu; Jiajun Du
Journal:  Gene       Date:  2012-12-28       Impact factor: 3.688

4.  miRNA and cancer; computational and experimental approaches.

Authors:  Yusuf Tutar
Journal:  Curr Pharm Biotechnol       Date:  2014       Impact factor: 2.837

Review 5.  Genetic variation in microRNA networks: the implications for cancer research.

Authors:  Bríd M Ryan; Ana I Robles; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

6.  Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Authors:  Xueqing Wang; Jiandong Wang; Henghui Ma; Jin Zhang; Xiaojun Zhou
Journal:  Med Oncol       Date:  2011-03-10       Impact factor: 3.064

7.  MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA.

Authors:  Juan Qu; Liang Zhao; Pengzhi Zhang; Juan Wang; Ning Xu; Wenjuan Mi; Xingwang Jiang; Changming Zhang; Juan Qu
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

8.  Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.

Authors:  Meiqun Wu; Normand Jolicoeur; Zhen Li; Linhua Zhang; Yves Fortin; Denis L'Abbe; Zhenbao Yu; Shi-Hsiang Shen
Journal:  Carcinogenesis       Date:  2008-03-19       Impact factor: 4.944

Review 9.  Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy.

Authors:  Mohammad Shahjahani; Elahe Khodadi; Mohammad Seghatoleslami; Javad Mohammadi Asl; Neda Golchin; Zeynab Deris Zaieri; Najmaldin Saki
Journal:  Oncol Rev       Date:  2015-03-09

10.  MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.

Authors:  Fabian Feiersinger; Elke Nolte; Sven Wach; Tilman T Rau; Nikolaos Vassos; Carol Geppert; Andreas Konrad; Susanne Merkel; Helge Taubert; Michael Stürzl; Roland S Croner
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

View more
  17 in total

1.  Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.

Authors:  Per Hydbring; Yinan Wang; Anne Fassl; Xiaoting Li; Veronica Matia; Tobias Otto; Yoon Jong Choi; Katharine E Sweeney; Jan M Suski; Hao Yin; Roman L Bogorad; Shom Goel; Haluk Yuzugullu; Kevin J Kauffman; Junghoon Yang; Chong Jin; Yingxiang Li; Davide Floris; Richard Swanson; Kimmie Ng; Ewa Sicinska; Lars Anders; Jean J Zhao; Kornelia Polyak; Daniel G Anderson; Cheng Li; Piotr Sicinski
Journal:  Cancer Cell       Date:  2017-04-10       Impact factor: 31.743

2.  Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.

Authors:  Yury O Nunez Lopez; Berta Victoria; Pawel Golusinski; Wojciech Golusinski; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2017-11-20

3.  MicroRNA-322 inhibits inflammatory cytokine expression and promotes cell proliferation in LPS-stimulated murine macrophages by targeting NF-κB1 (p50).

Authors:  Kai Zhang; Fengling Song; Xiaoxia Lu; Wenxun Chen; Chunxiao Huang; Lexing Li; Danyang Liang; Shengbo Cao; Hanchuan Dai
Journal:  Biosci Rep       Date:  2017-01-17       Impact factor: 3.840

4.  MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.

Authors:  Yu Shuang; Chao Li; Xuan Zhou; Yongwang Huang; Lun Zhang
Journal:  Oncol Rep       Date:  2017-08-03       Impact factor: 3.906

Review 5.  MicroRNA-195: a review of its role in cancers.

Authors:  Wanpeng Yu; Xiao Liang; Xiangdong Li; Yuan Zhang; Zhenqing Sun; Ying Liu; Jianxun Wang
Journal:  Onco Targets Ther       Date:  2018-10-17       Impact factor: 4.147

6.  Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway.

Authors:  Jun Dai; Rujia Wei; Peihai Zhang; Beihua Kong
Journal:  J Transl Med       Date:  2019-06-06       Impact factor: 8.440

7.  MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.

Authors:  Jing Zheng; Tingting Xu; Feng Chen; Ying Zhang
Journal:  Pathol Oncol Res       Date:  2019-01-12       Impact factor: 3.201

8.  Multi-view Co-training for microRNA Prediction.

Authors:  Mohsen Sheikh Hassani; James R Green
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

9.  MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.

Authors:  Li Chai; Xiao-Jing Kang; Zhen-Zhu Sun; Ming-Feng Zeng; Shi-Rong Yu; Yuan Ding; Jun-Qin Liang; Ting-Ting Li; Juan Zhao
Journal:  Cancer Manag Res       Date:  2018-05-03       Impact factor: 3.989

10.  Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression.

Authors:  Sining Shen; Ke Li; Ying Liu; Xianben Liu; Baoxing Liu; Yufeng Ba; Wenqun Xing
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-15       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.